Revolutionizing Biologics Production

A Bioprocess Innovation Company

Our Signature Approach

What Sets Us Apart

As the market for biologic drugs grow, we are developing novel cost-saving, disruptive ideas that employ state-of-the-art innovations in bioprocessing to produce cheaper drug substances. Our target is to produce high purity NBE (New Biological Entities) as well as API (Active Pharmaceutical Ingredients) that have had regulatory approvals. What sets our platform technologies apart will be very much lower CAPEX (Capital Expenditure) and subsequently COG (Cost of Goods).

Collaborations to Develop Malaysia’s Drug Discovery ecosystem

In realizing IBX Protech’s vision, key collaborators has rise to the occasion to ensure the success of Malaysia’s drug discovery ecosystem. With pride, and a collaborative spirit. We will successfully birth to the next generation biologic drugs for treating cancer, infective diseases and treat neurodegeneration.

What are we up to?

Custom-made low-footprint movable bioreactors with environmentally friendly sterilization and low carbon footprints. Without revealing too much, we shall use novel nanotechnology systems to deliver biologic proteins with 90-95% purity with almost zero carry-over of bioprocess chemicals

Pipeline projects

In realizing IBX Protech’s vision, key collaborators has rise to the occasion to ensure the success of Malaysia’s drug discovery ecosystem. With pride, and a collaborative spirit. We will successfully birth to the next generation biologic drugs for treating cancer, infective diseases and treat neurodegeneration.